NCT03864458View on ClinicalTrials.gov

Dose-finding Study of KHK7791 in Hyperphosphatemia Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

207

Participants

Timeline

Start Date

April 15, 2019

Primary Completion Date

December 10, 2019

Study Completion Date

December 31, 2019

Conditions
Hyperphosphatemia
Interventions
DRUG

KHK7791

oral administration

DRUG

Placebo

oral administration

Trial Locations (1)

Unknown

Study Site 1, Nagoya

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT03864458 - Dose-finding Study of KHK7791 in Hyperphosphatemia Patients | Biotech Hunter | Biotech Hunter